Biological and clinical impact of imbalanced progesterone receptor isoform ratios in breast cancer

Caroline A. Lamb(Consejo Nacional de Investigaciones Científicas y Técnicas), Claudia Lanari(Consejo Nacional de Investigaciones Científicas y Técnicas)
Endocrine Related Cancer
July 10, 2018
10.1530/erc-18-0179
Cited by 31

Related Papers

Interaction between FGFR-2, STAT5, and Progesterone Receptors in Breast Cancer
|Cancer Research|2011|87
Progestin and antiprogestin responsiveness in breast cancer is driven by the <scp>PRA</scp>/<scp>PRB</scp> ratio <i>via</i><scp>AIB</scp>1 or <scp>SMRT</scp> recruitment to the <scp><i>CCND</i></scp><i>1</i> and <scp><i>MYC</i></scp> promoters
|International Journal of Cancer|2014|39
Referee report. For: Impact of estrogen and progesterone hormone receptors on the progression of interferon-γ sensitized breast cancer cells [version 1; peer review: 1 approved, 1 approved with reservations, 1 not approved]
|Faculty of 1000 Research Ltd|2024|0